Masupirdine

In the following article we are going to analyze in depth Masupirdine, a figure/topic/date that has captured the public's attention in recent times. Throughout the next few lines we will explore its origins, its impact on current society, and the implications it has for the future. _Var1 has generated an intense debate between experts and ordinary people, and that is why it is crucial to understand all the facets of this phenomenon. Since its appearance, Masupirdine has unleashed a wave of conflicting opinions, and it will be our objective to draw up an impartial and exhaustive analysis that allows the reader to form an informed opinion on the subject.

Masupirdine
Identifiers
  • 1-(2-bromophenyl)sulfonyl-5-methoxy-3-indole
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC21H24BrN3O3S
Molar mass478.41 g·mol−1
3D model (JSmol)
  • CN1CCN(CC1)CC2=CN(C3=C2C=C(C=C3)OC)S(=O)(=O)C4=CC=CC=C4Br
  • InChI=1S/C21H24BrN3O3S/c1-23-9-11-24(12-10-23)14-16-15-25(20-8-7-17(28-2)13-18(16)20)29(26,27)21-6-4-3-5-19(21)22/h3-8,13,15H,9-12,14H2,1-2H3
  • Key:GWCYPEHWIZXYFZ-UHFFFAOYSA-N

Masupirdine is an investigational new drug that is being evaluated for the treatment of agitation in Alzheimer's dementia.[1] It is a selective 5-HT6 receptor antagonist.[2]

References

  1. ^ "Masupirdine - Suven Life Sciences". AdisInsight. Springer Nature Switzerland AG.
  2. ^ Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, et al. (February 2023). "Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders". Biomolecules. 13 (2): 309. doi:10.3390/biom13020309. PMC 9953539. PMID 36830678.


Stub icon

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.